Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer
暂无分享,去创建一个
J. Ledermann | J. Verweij | L. van Zuylen | J. Bridgewater | A. Sparreboom | P. de Bruijn | C. Mueller | F. Eskens | A. Planting | D. Bootle | I. Sklenar | L. Choi
[1] T. Thomas,et al. Structure-activity relations of s-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells , 2005, Breast Cancer Research and Treatment.
[2] Stephanie Green,et al. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria , 1992, Investigational New Drugs.
[3] C. Fabian,et al. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion , 1990, Investigational New Drugs.
[4] M. Hidalgo,et al. A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] H. Wallace,et al. Polyamines and colon cancer. , 2001, European journal of gastroenterology & hepatology.
[6] J P Pignon,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. , 2001, The New England journal of medicine.
[7] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Groen,et al. A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours , 2000, British Journal of Cancer.
[9] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.
[10] F. Lévi,et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Machover. A comprehensive review of 5‐fluorouracil and leucovorin in patients with metastatic colorectal carcinoma , 1997, Cancer.
[12] H. McLeod,et al. Comparison of 5‐Fluorouracil Pharmacokinetics in Whole Blood, Plasma, and Red Blood Cells in Patients with Colorectal Cancer , 1997, Pharmacotherapy.
[13] P. Rougier,et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] L. Demers,et al. Biochemical and growth‐modulatory effects of the new S‐adenosylmethionine decarboxylase inhibitor CGP 48664 in malignant and immortalized normal human breast epithelial cells in culture , 1995, International journal of cancer.
[15] S. Goodman,et al. Some practical improvements in the continual reassessment method for phase I studies. , 1995, Statistics in medicine.
[16] I. Fidler,et al. Treatment of nude mice with 4‐amidinoindan‐1‐one2′‐amidinohydrazone, a new S‐adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cells , 1995, Melanoma research.
[17] K. Nishioka,et al. Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, a new inhibitor of s-adenosylmethionine decarboxylase, produces cytostasis of human prostate-cancer in athymic nude-mice. , 1995, International journal of oncology.
[18] H. Mett,et al. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. , 1994, Cancer research.
[19] H. Mett,et al. New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity. , 1992, Cancer research.
[20] A. Pegg,et al. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.
[21] D. Perrier,et al. Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography. , 1985, Journal of chromatography.